Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Interest & Investment Income of -$39.9 million in Q1 2026, up 12.13% quarter-over-quarter from -$45.4 million in Q4 2025, and up 25.7% on a YoY basis from -$31.7 million in Q1 2025.
Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Interest & Investment Income history runs 17 years deep, the most recent figure standing at -$39.9 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 25.7% year-over-year to -$39.9 million; the TTM figure through Mar 2026 stood at -$181.2 million (up 19.69% YoY), while the FY2025 annual figure was -$195.1 million, up 18.08% from the prior year.
- Interest & Investment Income was -$39.9 million for Q1 2026 at Jazz Pharmaceuticals, up from -$45.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$39.9 million in Q1 2026 to a low of -$80.2 million in Q3 2022.
- Historically, Interest & Investment Income has averaged -$61.8 million across 5 years, with a median of -$63.2 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income sank 158.2% in 2022, then increased 27.11% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at -$74.1 million in 2022, then increased by 5.13% to -$70.3 million in 2023, then climbed by 27.11% to -$51.3 million in 2024, then grew by 11.41% to -$45.4 million in 2025, then gained by 12.13% to -$39.9 million in 2026.
- The last three Interest & Investment Income figures came in at -$39.9 million (Q1 2026), -$45.4 million (Q4 2025), and -$48.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | -39.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.90 Mn |
| Dec 31, 2025 | -45.41 Mn |
| Sep 30, 2025 | -48.58 Mn |
| Jun 30, 2025 | -47.36 Mn |
| Mar 31, 2025 | -53.70 Mn |
| Dec 31, 2024 | -51.26 Mn |
| Sep 30, 2024 | -58.70 Mn |
| Jun 30, 2024 | -62.02 Mn |
| Mar 31, 2024 | -66.12 Mn |
| Dec 31, 2023 | -70.32 Mn |
| Sep 30, 2023 | -71.50 Mn |
| Jun 30, 2023 | -73.47 Mn |
| Mar 31, 2023 | -74.15 Mn |
| Dec 31, 2022 | -74.13 Mn |
| Sep 30, 2022 | -80.24 Mn |
| Jun 30, 2022 | -63.19 Mn |
| Mar 31, 2022 | -70.68 Mn |
| Dec 31, 2021 | -88.60 Mn |
| Sep 30, 2021 | -93.37 Mn |
| Jun 30, 2021 | -69.42 Mn |